Differential Regulation of Th1/Th2 Cytokine Responses by Placental Protein 14
Author(s) -
Galit Mishan-Eisenberg,
Zipora Borovsky,
Matthew C. Weber,
Roi Gazit,
Mark L. Tykocinski,
Jacob Rachmilewitz
Publication year - 2004
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.173.9.5524
Subject(s) - microbiology and biotechnology , cytokine , priming (agriculture) , t cell , biology , chemokine , regulator , ex vivo , immunology , in vivo , immune system , gene , biochemistry , genetics , botany , germination
The potency of TCR signaling during primary CD4+ T cell activation influences initial cytokine expression patterns and subsequent polarization toward either Th1 or Th2 subsets. In this study, we demonstrate that the T cell inhibitor placental protein 14 (PP14; glycodelin) preferentially inhibits Th1 cytokine responses and chemokine expression when present during ex vivo priming of CD4+ T cells. PP14 synergizes with exogenously added IL-4 in skewing T cell responses. Significantly, PP14 impairs the down-regulation of GATA-3 transcriptional regulator expression that normally accompanies T cell activation, which is a prerequisite for Th1 development. Taken together, these data document for the first time the ability of PP14 to skew Th responses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom